Good afternoon :)
$
₹
Humana Inc

Humana Inc

HUM

NYSE
Asset Logo

Humana Inc

HUM

NYSE
$417.180.16% (-0.68)
$
₹
$417.180.16% (-0.68)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Healthcare Plans

Large Cap

With a market cap of $49.3B the stock is ranked 330

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

39.16
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

2.59
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$10.48
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.14
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0.88%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0.85%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 26 analysts reports

Buy
16 analysts
Hold
9 analysts
Sell
1 analyst

Price Upside

+11.31%

Earnings Growth

-46.53%

Rev. Growth

+25.56%

See Detailed Forecast

Company Profile

Company Profile

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
UnitedHealth Group Incorporated
UNH
UnitedHealth Group Incorporated
P/E Ratio
22.85
22.85
1Y Return
23.74%
23.74%
Buy Reco %
80.76
80.76
Elevance Health Inc
ELV
Elevance Health Inc
P/E Ratio
17.56
17.56
1Y Return
30.67%
30.67%
Buy Reco %
63.63
63.63
Centene Corp
CNC
Centene Corp
P/E Ratio
22.86
22.86
1Y Return
86.87%
86.87%
Buy Reco %
38.09
38.09
Molina Healthcare Inc
MOH
Molina Healthcare Inc
P/E Ratio
—
—
1Y Return
49.26%
49.26%
Buy Reco %
21.05
21.05
Oscar Health Inc
OSCR
Oscar Health Inc
P/E Ratio
24.03
24.03
1Y Return
105.06%
105.06%
Buy Reco %
27.27
27.27
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 11.31% growth, versus a trailing 3-year CAGR of -4.24%.

2026
Current$417.87Baseline
Analyst Target - 1 year
Target$465.13+11.31%

All values in $

202220232024202520262027$306.26$386.56$466.85Target+11.31%
2026
Current$417.87Baseline
Analyst Target - 1 year
Target$465.13+11.31%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 25.56% growth, versus a trailing 3-year CAGR of 11.75%.

2025
Current$129.66Baseline
Forecast for Dec 2026
High$164.99+27.24%
Average$162.80+25.56%
Low$161.57+24.61%

All values in $ Billion

20212022202320242025202683.6492.92106.44117.81129.66Low+24.61%Average+25.56%High+27.24%
2025
Current$129.66Baseline
Forecast for Dec 2026
High$164.99+27.24%
Average$162.80+25.56%
Low$161.57+24.61%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -46.53% growth, versus a trailing 3-year CAGR of -12.09%.

2025
Current$17.13Baseline
Forecast for Dec 2026
High$10.55-38.41%
Average$9.16-46.53%
Low$8.45-50.67%

All values in $

20212022202320242025202620.6325.2125.9916.1917.13Low-50.67%Average-46.53%High-38.41%
2025
Current$17.13Baseline
Forecast for Dec 2026
High$10.55-38.41%
Average$9.16-46.53%
Low$8.45-50.67%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

32.6
0.1
32.5
-0.7
39.6
1.1
40.8
0.6
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue29.6129.5429.3929.2132.1132.3832.6432.5139.6440.86
Net Income0.740.670.48-0.691.240.540.19-0.791.180.69
Net Profit Margin2.50%2.29%1.63%-2.37%3.87%1.68%0.59%-2.44%2.99%1.69%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareHealthcare Plans

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Humana Inc 39.162.591.14
UnitedHealth Group Incorporated22.853.501.03
Elevance Health Inc17.562.031.28
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare HUM with any stock or ETF
Compare HUM with any stock or ETF
Comparing from
HUM
UNH
ELV
Loading...

Frequently asked questions

  1. Humana Inc (HUM) share price today is $417.18 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $426.97 and a day low of $405.67.

  2. Humana Inc stock trades on NYSE under the ticker symbol HUM.

  3. Humana Inc's market capitalization is $49.28B as of November 5, 2026 at 2:29 AM IST.

  4. Humana Inc's price-to-earnings (P/E) ratio is 39.16 as of November 4, 2026.

  5. Humana Inc's price-to-book (P/B) ratio is 2.59 as of November 4, 2026.

  6. Yes, Humana Inc pays a dividend, with a current dividend yield of 0.85%.

  7. Yes, You can buy Humana Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Humana Inc shares in three steps: 1. Search Humana Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Humana Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Humana Inc (HUM) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0239 shares at the current price of $417.18.

Loading...